Stockreport

Anixa Biosciences Advances Breast Cancer Vaccine Toward Phase 2 After Positive Phase 1 Results; Cytovance Selected for cGMP Manufacturing [TheStreet.com]

Anixa Biosciences, Inc.  (ANIX) 
Last anixa biosciences, inc. earnings: 3/9 05:10 pm Check Earnings Report
PDF Phase 1 study met primary endpoints, showed safety and tolerability at the maximum tolerated dose, and generated protocol-defined immune responses in 74% of participant [Read more]